T2-weighted high-intensity signals in the basal ganglia as an interesting image finding in Unverricht-Lundborg disease

Epilepsy Research

Volumn 88, Issue 1, 2010, Pages 87-91

  Korja, Miikka ^a   Ferlazzo, Edoardo ^b   Soilu Hänninen, Merja ^c   Magaudda, Adriana ^d   Marttila, Reijo ^c   Genton, Pierre ^e   Parkkola, Riitta ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF MESSINA   (Italy)

^e CENTRE SAINT PAUL   (France)

Author keywords

Basal ganglia; T2 weighted; Unverricht Lundborg disease; White matter changes

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMAGE DISPLAY; LONG TERM CARE; MALE; MYOCLONUS EPILEPSY; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; SMOKING; WHITE MATTER;

ADOLESCENT; ADULT; ANTICONVULSANTS; BASAL GANGLIA; BODY MASS INDEX; BRAIN MAPPING; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; UNVERRICHT-LUNDBORG SYNDROME; VALPROIC ACID; YOUNG ADULT;

EID: 72249098367     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.09.018     Document Type: Article

References (13)

1. Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr. Scand. 100 (1999) 3-16
2. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., and Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol. 149 (1987) 351-356
3. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., Radner H., and Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43 (1993) 1683-1689
4. Huang C.C., Wai Y.Y., Chu N.S., Liou C.W., Pang C.Y., Shih K.D., and Wei Y.H. Mitochondrial encephalomyopathies: CT and MRI findings and correlations with clinical features. Eur. Neurol. 35 (1995) 199-205
5. Jeerakathil T., Wolf P.A., Beiser A., Massaro J., Seshadri S., D'Agostino R.B., and DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 35 (2004) 1857-1861
6. Koide R., Ikeuchi T., Onodera O., Tanaka H., Igarashi S., Endo K., Takahashi H., Kondo R., Ishikawa A., Hayashi T., et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat. Genet. 6 (1994) 9-13
7. Korja M., Kaasinen V., Lamusuo S., Parkkola R., Nagren K., and Marttila R.J. Substantial thalamostriatal dopaminergic defect in Unverricht-Lundborg disease. Epilepsia 48 (2007) 1768-1773
8. Kumru H., Santamaria J., Valldeoriola F., Marti M.J., and Tolosa E. Increase in body weight after pramipexole treatment in Parkinson's disease. Mov. Disord. 21 (2006) 1972-1974
9. Mascalchi M., Michelucci R., Cosottini M., Tessa C., Lolli F., Riguzzi P., Lehesjoki A.E., Tosetti M., Villari N., and Tassinari C.A. Brainstem involvement in Unverricht-Lundborg disease (EPM1): an MRI and (1)H MRS study. Neurology 58 (2002) 1686-1689
10. Pennacchio L.A., Lehesjoki A.E., Stone N.E., Willour V.L., Virtaneva K., Miao J., D'Amato E., Ramirez L., Faham M., Koskiniemi M., Warrington J.A., Norio R., de la Chapelle A., Cox D.R., and Myers R.M. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271 (1996) 1731-1734
11. Vermeer S.E., Hollander M., van Dijk E.J., Hofman A., Koudstaal P.J., and Breteler M.M. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34 (2003) 1126-1129
12. Yoshii F., Tomiyasu H., and Shinohara Y. Fluid attenuation inversion recovery (FLAIR) images of dentatorubropallidoluysian atrophy: case report. J. Neurol. Neurosurg. Psychiatry 65 (1998) 396-399
13. Ziyeh S., Thiel T., Spreer J., Klisch J., and Schumacher M. Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy. Epilepsia 43 (2002) 1101-1105